Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer.
Petrylak DP, Macarthur R, O'Connor J, Shelton G, Weitzman A, Judge T, England-Owen C, Zuech N, Pfaff C, Newhouse J, Bagiella E, Hetjan D, Sawczuk I, Benson M, Olsson C.
Petrylak DP, et al. Among authors: newhouse j.
Semin Oncol. 1999 Oct;26(5 Suppl 17):28-33.
Semin Oncol. 1999.
PMID: 10604266
Clinical Trial.